Lawn, W., Hao, X., Konova, A. B., Haney, M., Cooper, Z. D., Van Dam, N., Glimcher, P., & Bedi, G. (2025). Value signals guiding choices for cannabis versus non-drug rewards in people who use cannabis near-daily. Psychopharmacology. https://doi.org/10.1007/s00213-025-06746-6

Pravosud, V., Glantz, S., Keyhani, S., Ling, P. M., Lempert, L. K., Hoggatt, K. J., Hasin, D., Nguyen, N., Graham, F. J. L., & Cohen, B. E. (2024). Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021. International Journal of Drug Policy, 134, 104618. https://doi.org/10.1016/j.drugpo.2024.104618

Brezing, C. A., Sibai, M., Choi, C. J., Mitra, S., Mariani, J. J., Naqvi, N., Mahony, A. L., Brooks, D., Pavlicova, M., & Levin, F. R. (2023). Open-label pilot of lorcaserin (a serotonin 2C-receptor agonist) for cannabis use disorder. Journal of Substance Use, 29(4), 487–494. https://doi.org/10.1080/14659891.2023.2202760

Luba, R., Madera, G., Schusterman, R., Kolodziej, A., Hodgson, I., & Comer, S. D. (2024). Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics, JPET-AR-2024-002129. https://doi.org/10.1124/jpet.124.002129

Rahmon, D., Zalikha, A. K., Mazur, M., Hajj Hussein, I., & El-Othmani, M. M. (2023). Cannabis use disorder is associated with shorter length of stay and increased home discharge after primary total joint arthroplasty: a propensity-weighted analysis. Arthroplasty, 5(1). https://doi.org/10.1186/s42836-023-00164-9

McGraw, K. E., Nigra, A. E., Klett, J., Sobel, M., Oelsner, E. C., Navas-Acien, A., Hu, X., & Sanchez, T. R. (2023). Blood and Urinary Metal Levels among Exclusive Marijuana Users in NHANES (2005–2018). Environmental Health Perspectives, 131(8). https://doi.org/10.1289/ehp12074

Walsh, C. A., Struble, C. A., Aharonovich, E., Shmulewitz, D., Borodovsky, J., Habib, M. I., Budney, A., Livne, O., & Hasin, D. S. (2023). Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing. Drug and Alcohol Dependence Reports, 7, 100161. https://doi.org/10.1016/j.dadr.2023.100161

Gonçalves, P. D., Levy, N. S., Segura, L. E., Bruzelius, E., Boustead, A. E., Hasin, D. S., Mauro, P. M., & Martins, S. S. (2022). Cannabis Recreational Legalization and Prevalence of Simultaneous Cannabis and Alcohol Use in the United States. Journal of General Internal Medicine, 38(6), 1493–1500. https://doi.org/10.1007/s11606-022-07948-w

Hasin, D. (2023). Legalization of cannabis for medical and recreational use. European Psychiatry, 66(S1), S20–S21. https://doi.org/10.1192/j.eurpsy.2023.83

Manuzak, J. A., Granche, J., Tassiopoulos, K., Rower, J. E., Knox, J. R., Williams, D. W., Ellis, R. J., Goodkin, K., Sharma, A., & Erlandson, K. M. (2023). Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac699

Jiménez, C., Ventura‐Cots, M., Sala, M., Calafat, M., Garcia‐Retortillo, M., Cirera, I., Cañete, N., Soriano, G., Poca, M., Simón‐Talero, M., Altamirano, J., Lucey, M., Garcia‐Tsao, G., Brown, R. S., Schwabe, R. F., Verna, E. C., Schnabl, B., Bosques‐Padilla, F., Mathurin, P., … Vargas, V. (2022). Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH). Liver International, 42(5), 1109–1120. Portico. https://doi.org/10.1111/liv.15207